Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
45.52197
male
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
0
5
$11-$25k
9
40,904
23,198.3906
26,326
14.5
white
22.5
12
0.843994
0.790894
3
0
0
no
0.8
0.75
no dnr
7
101
7.099609
104
28
36.69531
null
2.5
0.699951
0.699951
138
null
125
21
null
0
0
no(M2 and SIP pres)
0
872
0
67.69897
male
0
6
COPD
COPD/CHF/Cirrhosis
3
10
under $11k
0
13,530
8,061.7969
8,794
27
white
18.796875
31
0.86499
0.776978
1
1
0
no
0.7
0.6
no dnr
6
103
2.799805
65
24
38.19531
310
2.199707
null
0.799927
137
7.439453
126
8
2,895
null
2
no(M2 and SIP pres)
2
537
1
72.93597
male
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
1
7
under $11k
0
91,573
50,005.9688
52,111
73
white
58
95
0.007
0.001
6
0
0
no
null
null
no dnr
4
58
10.898438
60
10
38.09375
136.65625
null
null
0.599976
129
7.389648
112
26
670
null
1
<2 mo. follow-up
1
4
1
67.01398
female
0
17
MOSF w/Malig
ARF/MOSF
1
10
under $11k
0
49,608
30,856.4219
29,589
15.666664
white
29.699219
24
0.368958
0.250977
13
0
0
metastatic
0.2
0.2
dnr after sadm
2
118
13
65
42
37.89844
253.3125
2.599609
1.699951
0.5
142
7.439453
91
13
6,340
1
0
adl>=4 (>=5 if sur)
0
414
1
44.64297
female
0
44
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
127,319
null
null
32.25
other
23.796875
32
0.85791
0.80896
2
0
0
no
null
null
no dnr
44
53
5.299805
70
24
35.09375
357.125
null
2.299805
1.799805
131
7.489258
82
54
940
null
null
no(M2 and SIP pres)
1.867188
842
1
80.46295
female
0
96
ARF/MOSF w/Sepsis
ARF/MOSF
0
17
null
41
null
143,812.875
139,211
36.25
white
29.398438
36
0.373962
0.255981
5
0
0
no
0.3
0.1
no dnr
96
155
9.599609
125
36
36.39844
142.84375
null
null
1.399902
128
7.509766
1.399902
26
3,270
null
0
SIP>=30
0
868
0
72.16998
female
0
10
COPD
COPD/CHF/Cirrhosis
2
16
under $11k
0
10,077
6,900.418
7,553
10
white
18.699219
18
0.807983
0.689941
1
0
0
yes
0.5
0.5
dnr before sadm
-1
85
5.799805
105
24
35.39844
null
null
0.799927
1
143
null
77
13
3,425
0
1
<2 mo. follow-up
1
42
1
60.668
male
0
6
Lung Cancer
Cancer
1
12
$11-$25k
0
15,007
7,510.8633
3,060
15
white
16.597656
7
0.725952
0.452942
1
0
0
metastatic
null
null
no dnr
6
133
10.398438
135
26
35.59375
270
null
0.5
1.099854
139
7.439453
247
21
3,745
0
null
<2 mo. follow-up
0.494751
40
1
76.41595
female
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
0
13,907
8,406.4141
8,812
14
black
24.796875
48
0.75293
0.674927
1
1
0
no
0.6
0.55
no dnr
7
115
0.799927
70
32
38.19531
288
1.799805
0.699951
2.099609
132
7.359375
106
77
1,445
null
null
null
3.365723
141
1
56.57199
female
0
11
Lung Cancer
Cancer
1
13
null
0
11,383
7,596.5508
7,687
11
white
25.097656
17
0.541992
0.218994
1
0
0
metastatic
0.7
0.4
no dnr
11
120
6.099609
125
30
35.79688
263.3125
1.199951
3.799805
1.099854
137
7.389648
69
26
3,500
1
1
no(M2 and SIP pres)
1
867
0
28.786
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
>$50k
0
31,965
20,141.1094
20,082
14
black
27.398438
46
0.869995
0.823975
1
0
0
no
0.7
0.7
no dnr
10
65
1.299805
140
13
38.5
167.5
2.5
4.599609
1.899902
143
7.349609
53
39
1,475
1
1
no(M2 and SIP pres)
1
867
0
75.39197
female
0
8
Lung Cancer
Cancer
1
12
$25-$50k
0
7,706
5,489.1211
5,390
6.5
white
23
13
0.537964
0.214996
1
0
0
metastatic
0.5
0.3
dnr after sadm
2
60
20.296875
115
28
36.29688
156.65625
2.5
0.399963
0.5
137
7.489258
99
14
1,275
null
0
<2 mo. follow-up
0
11
1
54.18799
male
0
20
CHF
COPD/CHF/Cirrhosis
2
12
$25-$50k
0
51,179
32,586.8594
33,527
21
white
26.296875
43
0.822998
0.711914
1
1
0
no
0.6
0.55
no dnr
20
153
13.099609
145
12
37.69531
187.5
null
null
1.199951
138
7.479492
141
23
3,055
0
0
no(M2 and SIP pres)
0
866
0
72.68195
male
1
20
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
$11-$25k
9
96,468
54,964.375
56,554
37
white
20.296875
29
0.797974
0.731934
2
0
0
no
0.2
0.15
dnr after sadm
5
67
16.296875
115
37
36.29688
300
2.899902
1.599854
0.899902
136
7.319336
95
18
1,110
null
0
<2 mo. follow-up
0
20
1
69.14398
female
1
48
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
81,683
50,131.6562
49,244
26.25
white
38.09375
56
0.420959
0.300964
4
0
0
no
0.6
0.4
dnr after sadm
31
159
12
125
8
38
152.5
3.399902
0.399963
5
145
7.639648
198
102
5,040
null
4
<2 mo. follow-up
4
48
1
25.51399
female
1
24
ARF/MOSF w/Sepsis
ARF/MOSF
1
13
>$50k
0
214,081
null
null
43.666657
white
24.796875
34
0.85791
0.80896
31
0
0
no
null
null
dnr after sadm
22
120
3.199707
125
10
36
236
2.5
3.299805
0.799927
140
7.329102
121
13
1,165
null
1
<2 mo. follow-up
1
24
1
63.16199
female
0
31
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
9
46,093
30,062.0469
32,577
23.75
white
28.699219
44
0.645996
0.545898
1
0
0
yes
null
null
no dnr
31
93
15.5
100
22
36.59375
292
null
0.399963
0.799927
140
7.399414
130
21
2,200
null
null
<2 mo. follow-up
2.745606
49
1
76.474
male
0
10
Colon Cancer
Cancer
1
16
>$50k
0
30,924
17,635.5938
13,814
14
white
17.796875
17
0.781982
0.543945
1
0
0
metastatic
1
1
no dnr
10
113
12.898438
75
29
34.5
270
2.199707
null
2.599609
137
7.349609
49
30
1,145
0
5
no(M2 and SIP pres)
5
865
0
55.35898
female
1
18
Lung Cancer
Cancer
2
11
$11-$25k
9
20,520
13,153.9531
12,673
15.666664
black
38.195313
28
0.135986
0.007
1
1
0
metastatic
null
null
no dnr
18
85
6.099609
68
14
37.69531
null
3.699707
0.399963
1.399902
144
null
128
16
null
null
null
<2 mo. follow-up
3.756348
18
1
65.23499
female
0
7
Cirrhosis
COPD/CHF/Cirrhosis
3
8
under $11k
0
5,937
4,279.6328
4,729
5.5
white
15.798828
22
0.821899
0.710938
1
0
0
no
0.8
0.6
no dnr
7
108
12
130
8
35.59375
312
3.899902
0.799927
2.899902
136
7.40918
687
43
1,680
0
0
null
0
864
0
45.142
female
0
12
Cirrhosis
COPD/CHF/Cirrhosis
2
7
under $11k
0
12,627
8,946.6797
10,156
10.5
other
16.398438
31
0.893921
0.822998
1
0
0
no
0.9
0.6
no dnr
12
165
22.597656
120
27
38.59375
56
2.099609
2.199707
1.799805
142
7.349609
183
28
855
6
3
no(M2 and SIP pres)
3
864
0
63.56497
male
0
6
CHF
COPD/CHF/Cirrhosis
2
6
under $11k
0
3,223
2,557.2129
2,828
8
white
24.097656
50
0.817993
0.703979
1
0
0
no
null
null
no dnr
6
63
10.099609
131
20
38.19531
308
3.199707
null
0.699951
138
7.459961
169
8
1,100
0
0
<2 mo. follow-up
0
55
1
21.489
female
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
1
2
null
0
9,570
6,218.1367
6,122
15
black
18.796875
23
0.940918
0.919922
1
1
0
no
1
1
no dnr
6
105
11.398438
115
24
38.09375
134.6875
null
null
1
136
7.439453
131
23
2,720
0
null
no(M2 and SIP pres)
0.494751
863
0
68
female
0
5
COPD
COPD/CHF/Cirrhosis
2
11
null
0
12,333
null
null
22
white
19.898438
24
0.814941
0.700928
1
0
0
yes
null
null
no dnr
5
108
11.5
105
22
36.69531
260
null
null
0.599976
137
7.459961
136
11
2,705
2
null
<2 mo. follow-up
1.838867
29
1
65.23798
male
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
29,142
18,768.1875
18,177
26.5
white
28
58
0.684937
0.591919
1
0
0
yes
0.6
0.4
no dnr
12
33
11.199219
150
36
39.59375
157.5
2.399902
2.599609
3.899902
135
7.369141
38
55
80
null
0
no(M2 and SIP pres)
0
574
1
81.05695
male
0
72
ARF/MOSF w/Sepsis
ARF/MOSF
1
18
null
0
null
null
null
28.25
white
31.296875
68
0.524902
0.408997
5
1
0
no
0.7
0.5
no dnr
72
65
34.796875
65
22
36.09375
217.5
1.799805
37.59375
4.199219
128
7.359375
97
49
5,465
null
null
null
3.155762
861
0
49.18298
male
0
18
ARF/MOSF w/Sepsis
ARF/MOSF
4
8
$11-$25k
0
28,282
18,109.2656
17,542
18.666656
white
28.796875
52
0.792969
0.724976
1
1
0
no
0.85
0.75
dnr after sadm
4
73
6.899414
95
26
35.69531
528
null
0.799927
1.899902
140
7.459961
109
62
1,405
0
0
<2 mo. follow-up
0
41
1
83.77496
male
0
7
COPD
COPD/CHF/Cirrhosis
1
7
under $11k
0
12,501
8,251.3281
8,286
11.5
black
22.199219
41
0.715942
0.557983
1
0
0
no
0.7
0.6
no dnr
7
45
14.798828
105
27
38.89844
182.5
null
1.5
5.899414
129
7.339844
95
82
115
0
0
no(M2 and SIP pres)
0
860
0
63.95297
female
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
41
96,337
52,540.7188
47,087
36.5
white
27.097656
42
0.520996
0.404968
11
0
0
no
0.5
0.25
dnr after sadm
3
97
8.699219
76
10
35.59375
null
3.899902
1.199951
1.199951
139
null
82
4
null
null
null
<2 mo. follow-up
2.49707
8
1
69.86395
male
0
3
COPD
COPD/CHF/Cirrhosis
3
16
under $11k
0
2,876
1,988.1016
1,959
1
black
11.798828
16
0.914917
0.856934
1
0
0
no
0.9
0.65
no dnr
3
140
7.099609
125
10
37.79688
313.3125
2.299805
null
0.599976
129
7.469727
128
5
6,280
0
0
<2 mo. follow-up
0
15
1
52.24899
female
0
8
Lung Cancer
Cancer
2
15
>$50k
0
6,711
4,352.8633
4,250
5
white
15.699219
13
0.760986
0.507935
1
0
0
metastatic
0.6
0.5
no dnr
8
161
9.798828
50
14
38.69531
366.625
null
null
1.5
152
7.419922
144
12
2,780
2
1
no(M2 and SIP pres)
1
110
1
52.59399
male
0
21
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
$25-$50k
0
56,633
34,006.4062
32,846
26.333328
white
23.097656
25
0.85498
0.804932
1
0
0
no
0.6
0.4
no dnr
21
73
15.599609
105
24
37.89844
226.90625
null
1.099854
0.599976
133
7.40918
122
7
null
null
6
adl>=4 (>=5 if sur)
6
276
1
76.72296
female
1
15
ARF/MOSF w/Sepsis
ARF/MOSF
3
9
null
0
116,654
67,757.1875
59,338
36
white
44.195313
80
0.13797
0.063995
24
0
0
no
0.2
0.1
dnr after sadm
5
62
6.099609
105
24
37
140
null
1.099854
1.199951
142
7.519531
367
41
6,315
null
3
<2 mo. follow-up
3
15
1
78.09698
female
1
12
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
under $11k
0
63,577
null
null
53
white
43.296875
77
0.266968
0.16098
1
1
0
no
null
null
dnr after sadm
8
100
7.599609
64
24
39.29688
null
3.899902
1.399902
0.899902
141
null
92
6
null
null
6
<2 mo. follow-up
6
12
1
76.698
male
1
5
Coma
Coma
1
16
$25-$50k
61
3,462
2,690.6816
2,795
8
white
16.398438
20
0.507935
0.435974
1
0
0
no
null
null
dnr after sadm
1
113
9.398438
125
10
37.79688
346.625
3.399902
2.099609
1
142
7.449219
190
13
2,990
null
null
<2 mo. follow-up
2.037598
5
1
64.96399
male
1
5
MOSF w/Malig
ARF/MOSF
2
12
$11-$25k
0
42,713
24,700.4375
22,499
45
white
48.398438
112
0.011
0.002
12
1
0
metastatic
null
null
dnr after sadm
3
113
13.898438
115
26
39.19531
96.65625
null
1.599854
1
142
7.399414
114
18
3,270
null
null
<2 mo. follow-up
2.539551
5
1
53.63397
female
0
50
MOSF w/Malig
ARF/MOSF
1
14
$11-$25k
0
204,110
114,735.125
101,973
33.25
white
33.09375
54
0.291992
0.181976
13
0
0
metastatic
0.7
0.5
dnr after sadm
24
58
3.399902
105
10
35.5
380
null
3.799805
0.899902
130
7.489258
97
15
1,050
null
0
adl>=4 (>=5 if sur)
0
156
1
72.33099
female
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
2
5
under $11k
0
34,368
20,941.1094
20,411
16.666656
black
22.5
31
0.803955
0.738892
1
1
0
no
0.7
0.9
no dnr
19
77
5.699219
65
20
36.29688
null
null
0.599976
1.099854
142
null
114
12
3,900
0
0
no(M2 and SIP pres)
0
854
0
45.38498
female
1
8
MOSF w/Malig
ARF/MOSF
1
null
null
0
43,002
25,865.5781
28,655
21
black
44.796875
75
0.053993
0.017998
9
0
0
metastatic
0.2
0.1
dnr after sadm
7
65
12.599609
85
16
36.39844
null
3.099609
0.699951
1.399902
137
null
97
14
4,025
null
null
<2 mo. follow-up
3.200195
8
1
50.82797
male
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
under $11k
0
13,347
8,863.7734
8,565
17
black
29.097656
53
0.781982
0.710938
1
0
0
no
0.8
0.6
no dnr
6
112
18.699219
135
28
36.5
175
2.299805
1.699951
2.5
133
7.299805
220
56
955
0
null
<2 mo. follow-up
0.494751
18
1
75.02795
male
0
11
COPD
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
24,806
15,019.7969
15,288
18.5
white
30.699219
34
0.611938
0.424988
1
1
0
no
null
null
no dnr
11
112
3.099609
145
67
38.29688
106.10938
3
6.199219
1
138
7.419922
135
9
3,420
0
0
no(M2 and SIP pres)
0
853
0
63.56998
female
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
0
46,649
28,247.2812
32,706
20
white
28.5
50
0.740967
0.659912
1
0
0
no
0.7
0.6
no dnr
14
77
9.199219
120
26
38
323.75
null
1.899902
1.699951
136
7.509766
114
24
3,850
null
0
no(M2 and SIP pres)
0
853
0
76.61597
female
0
4
CHF
COPD/CHF/Cirrhosis
3
10
null
0
6,633
4,034.3262
3,425
7
white
16.199219
19
0.86792
0.780884
1
1
0
no
0.8
0.6
no dnr
4
112
15.898438
165
46
37.69531
null
3.699707
null
0.899902
138
null
129
23
1,110
0
null
no(M2 and SIP pres)
0.494751
853
0
63.87399
female
1
8
Coma
Coma
0
null
null
61
179,570
96,443
86,563
50.5
white
33.695313
78
0.065994
0.035995
21
0
0
no
null
null
dnr after sadm
8
63
5.899414
135
10
35.5
220
2.099609
2.899902
2.799805
142
7.509766
374
62
3,760
null
null
<2 mo. follow-up
2.06543
8
1
65.42896
male
1
11
ARF/MOSF w/Sepsis
ARF/MOSF
3
11
null
0
43,352
25,331.6875
24,829
35
white
27.699219
30
0.668945
0.572998
2
0
0
yes
0.5
0.3
dnr after sadm
9
58
12.099609
110
8
38.29688
340
null
0.5
2.699707
145
7.369141
299
50
5,645
null
0
<2 mo. follow-up
0
11
1
69.008
male
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
$25-$50k
100
20,466
11,629.3125
11,087
32
white
54.796875
102
0
0
2
0
0
no
null
null
dnr after sadm
2
62
18.097656
135
41
38.89844
226.65625
null
0.5
1
132
7.569336
184
17
6,840
null
0
<2 mo. follow-up
0
3
1
77.19397
male
1
23
ARF/MOSF w/Sepsis
ARF/MOSF
0
9
null
26
216,528
124,308.75
116,326
36.333313
white
27.199219
42
0.477966
0.359985
33
0
0
no
null
null
dnr after sadm
23
100
11.5
74
20
37.59375
123.32812
null
null
1.899902
139
7.289062
66
27
null
null
1
<2 mo. follow-up
1
23
1
62.88797
male
0
22
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
null
0
140,338
81,788.9375
85,116
31
black
23.597656
48
0.766968
0.692993
10
0
0
no
0.95
0.95
no dnr
22
95
12.5
110
24
37.79688
169.375
null
null
1.199951
136
7.429688
98
21
2,870
null
0
SIP>=30
0
847
0
61.12299
female
1
15
Coma
Coma
1
14
$25-$50k
94
38,083
22,628.7812
22,674
16
white
25.5
27
0.187988
0.129974
3
0
0
no
0.1
0.1
dnr after sadm
6
125
19.296875
105
26
37.19531
343.4375
3.799805
0.699951
1.399902
137
7.419922
285
36
1,093
null
1
<2 mo. follow-up
1
15
1
43.38098
female
0
40
ARF/MOSF w/Sepsis
ARF/MOSF
3
16
$25-$50k
41
95,022
60,139.0938
61,095
25.25
black
37
64
0.481995
0.363953
1
0
0
no
0.65
0.6
no dnr
40
50
5
145
40
33.89844
55
4.699219
4.099609
2.299805
152
7.439453
393
25
2,750
null
0
no(M2 and SIP pres)
0
847
0
61.78497
male
0
51
ARF/MOSF w/Sepsis
ARF/MOSF
2
15
null
100
113,757
66,821.8125
77,115
30
white
28.199219
49
0.276978
0.168976
2
0
0
no
0.2
0.1
dnr after sadm
12
108
6.5
105
26
35.69531
150
null
null
0.5
134
7.319336
80
11
1,390
null
0
adl>=4 (>=5 if sur)
0
847
0
70.02295
male
1
12
MOSF w/Malig
ARF/MOSF
1
12
under $11k
0
146,048
87,808.8125
88,876
43
black
59.796875
104
0
0
34
0
0
yes
0.2
0.1
dnr after sadm
5
67
11.699219
105
12
38.69531
326.625
2.099609
2.299805
0.599976
130
7.469727
157
17
1,890
null
0
<2 mo. follow-up
0
12
1
66.41199
female
1
14
MOSF w/Malig
ARF/MOSF
2
7
under $11k
0
29,635
18,554.125
18,661
20.333328
white
27.597656
46
0.448975
0.329956
8
0
0
metastatic
0.4
0.2
no dnr
14
73
11.699219
130
10
37.69531
104
1.5
1.599854
0.699951
136
7.429688
125
11
2,225
null
0
<2 mo. follow-up
0
14
1
67.737
male
1
9
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
44
77,412
43,302.9688
46,105
45
white
32.796875
93
0.372986
0.254944
3
1
0
no
0.3
0.2
dnr after sadm
3
118
10.398438
105
24
37
266.625
null
0.599976
0.799927
134
7.399414
128
9
1,150
null
0
<2 mo. follow-up
0
9
1
46.65598
male
0
15
CHF
COPD/CHF/Cirrhosis
2
16
null
0
45,527
25,871.6406
26,413
21.666656
black
42
59
0.55188
0.35498
1
0
0
no
0.65
0.55
no dnr
15
95
13.699219
85
20
36
null
null
0.699951
1.099854
138
null
104
18
3,950
0
0
no(M2 and SIP pres)
0
425
1
70.073
female
0
5
CHF
COPD/CHF/Cirrhosis
4
10
$11-$25k
0
4,990
3,376.4356
3,987
11
black
19.097656
31
0.821899
0.709961
1
1
0
yes
0.7
0.2
no dnr
5
75
12.298828
60
14
36
493.3125
null
null
6.299805
137
7.539062
108
53
0
5
5
null
5
72
1
56.75598
male
1
6
MOSF w/Malig
ARF/MOSF
1
12
$25-$50k
9
31,855
18,527.2031
19,456
35
white
49.296875
84
0.046997
0.014999
1
0
0
yes
0.4
0.2
dnr after sadm
6
80
8
126
22
36
247.59375
3.399902
0.599976
0.599976
132
7.439453
105
6
null
null
0
<2 mo. follow-up
0
6
1
77.17694
male
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
9
12,136
7,305.8594
6,994
25
white
22.796875
45
0.755981
0.678955
1
0
0
no
0.55
0.5
dnr after sadm
4
135
9.898438
125
38
36.69531
398
2.899902
1.599854
2.299805
136
7.589844
77
28
4,425
null
null
<2 mo. follow-up
2.39209
5
1
64.047
female
0
22
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
under $11k
0
44,905
26,915.875
27,255
21.666656
black
32.398438
52
0.658936
0.56189
1
0
0
no
0.6
0.5
no dnr
22
110
14.199219
95
24
35.79688
null
null
null
0.699951
130
null
85
11
null
null
0
null
0
716
1
56.18298
female
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
0
7
$25-$50k
44
59,066
33,900.4375
29,200
40
white
48.09375
90
0.039993
0.011999
11
0
0
no
0
0
dnr after sadm
3
65
16.898438
125
24
36.5
376
null
null
1.899902
132
7.439453
257
31
1,425
null
1
<2 mo. follow-up
1
5
1
65.31696
female
0
67
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
null
37
null
105,694.75
107,273
25.5
white
31.699219
37
0.42395
0.304993
6
0
0
no
0.4
0.3
no dnr
67
60
20.597656
125
10
38.39844
276.625
2.399902
null
0.899902
135
7.429688
179
9
990
null
0
no(M2 and SIP pres)
0
839
0
58.198
male
1
14
Coma
Coma
2
8
$11-$25k
94
35,896
null
null
17
white
19.796875
24
0.428955
0.35498
1
1
0
no
0.05
0.02
dnr after sadm
2
47
12.898438
65
10
38
370
2.699707
5.099609
3.5
128
7.399414
155
63
1,300
null
0
<2 mo. follow-up
0
14
1
56.646
male
0
15
CHF
COPD/CHF/Cirrhosis
3
11
$11-$25k
0
31,154
18,346.0625
17,082
16.666656
black
35.09375
50
0.655884
0.47998
1
1
0
no
0.9
0.8
no dnr
15
62
23.699219
130
8
36.79688
252.5
null
2.5
1.299805
149
7.399414
212
51
3,885
0
5
adl>=4 (>=5 if sur)
5
74
1
75.94299
female
0
22
CHF
COPD/CHF/Cirrhosis
3
null
under $11k
0
16,361
12,048.6797
12,880
8.666664
black
23.796875
42
0.771973
0.636963
1
1
0
no
0.8
0.6
no dnr
22
65
17
115
32
36.89844
372
29
1
5.599609
145
7.329102
92
127
3,205
2
1
no(M2 and SIP pres)
1
152
1
57.84799
male
0
8
Cirrhosis
COPD/CHF/Cirrhosis
2
10
under $11k
0
32,299
20,089.7656
20,786
19.5
white
19
25
0.785889
0.655884
4
0
0
no
0.7
0.7
no dnr
8
117
21.898438
70
24
38.09375
null
3.299805
1.099854
1.199951
135
null
149
17
1,070
1
0
no(M2 and SIP pres)
0
638
1
64.61896
male
0
15
MOSF w/Malig
ARF/MOSF
1
null
null
0
39,790
26,220
25,733
8.333328
white
24.296875
18
0.521973
0.405945
16
0
0
metastatic
0
0
dnr after sadm
1
69
17.898438
138
22
36.5
null
2.199707
0.699951
0.599976
144
null
203
6
null
null
null
<2 mo. follow-up
2.929199
25
1
64.04895
male
0
7
CHF
COPD/CHF/Cirrhosis
2
18
>$50k
0
6,522
4,604.7148
4,295
7.5
white
16.5
24
0.895996
0.825928
1
1
0
no
null
null
no dnr
7
71
12.099609
80
24
36.59375
null
2.399902
0.799927
0.799927
135
null
76
9
1,350
0
0
no(M2 and SIP pres)
0
837
0
53.172
female
1
6
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
$11-$25k
0
120,668
67,220.1875
63,222
58
asian
32.796875
45
0.608887
0.50293
23
1
0
no
null
null
dnr after sadm
6
66
9.298828
84
24
37.59375
null
1
3
0.799927
134
null
105
2
2,300
null
1
<2 mo. follow-up
1
6
1
61.54398
male
0
11
COPD
COPD/CHF/Cirrhosis
2
3
null
0
12,650
7,735.4883
7,142
15
white
19.097656
22
0.823975
0.712891
1
0
0
metastatic
0.6
0.5
no dnr
11
58
10.398438
70
24
34.89844
633.25
null
null
1.5
131
7.509766
238
32
1,400
5
0
<2 mo. follow-up
0
48
1
49.67297
female
0
5
Colon Cancer
Cancer
1
10
under $11k
0
5,648
null
null
14
black
45.296875
65
0.181976
0.014999
1
0
0
metastatic
0.02
0.02
dnr after sadm
1
73
10.199219
100
20
36.69531
401.625
3.699707
1.099854
0.799927
146
6.919922
195
5
5,230
null
0
<2 mo. follow-up
0
11
1
42.01498
male
0
5
ARF/MOSF w/Sepsis
ARF/MOSF
2
13
$11-$25k
0
12,763
9,769.4062
11,388
16
white
23.199219
32
0.878906
0.835938
1
0
0
no
0.8
0.8
no dnr
5
72
12
115
24
36.59375
262.9375
null
null
0.899902
140
7.389648
157
21
2,085
null
null
null
2.024414
835
0
67.73999
male
0
6
Colon Cancer
Cancer
1
12
$11-$25k
0
5,624
3,785.209
3,887
7
white
4.5
12
0.927979
0.829956
1
0
0
metastatic
0.8
0.6
no dnr
6
62
9.398438
135
31
35.69531
223.3125
null
2.299805
1.899902
138
7.429688
69
30
785
0
0
no(M2 and SIP pres)
0
285
1
69.83398
female
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
under $11k
0
65,899
38,949.6562
40,096
32
white
22.597656
32
0.810913
0.748901
1
1
0
no
0.5
0.5
no dnr
19
118
10.699219
115
32
38.39844
97.95312
2.399902
1.099854
1.799805
134
7.449219
221
47
1,880
null
1
adl>=4 (>=5 if sur)
1
581
1
49.02399
male
0
6
Cirrhosis
COPD/CHF/Cirrhosis
4
13
null
0
5,844
3,874.1211
5,229
8
black
21.597656
18
0.824951
0.714966
1
0
0
no
0.8
0.6
no dnr
6
68
18.898438
80
23
35.39844
244
null
null
2.299805
126
7.519531
326
75
3,145
0
0
<2 mo. follow-up
0
9
1
45.24298
female
0
18
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
67,484
39,542.9375
41,029
18.666656
white
24
40
0.832886
0.776978
6
0
0
no
0.9
0.7
no dnr
18
87
12
75
30
35.69531
181.8125
null
null
1.399902
139
7.359375
206
31
700
null
null
null
2.758789
832
0
58.01498
female
1
32
ARF/MOSF w/Sepsis
ARF/MOSF
1
6
under $11k
0
265,216
147,972.25
143,792
47
other
30.199219
61
0.691895
0.600952
4
0
0
no
0.1
0.8
dnr after sadm
31
117
21.699219
120
40
38
165
null
null
1.399902
143
7.40918
181
64
2,085
null
6
<2 mo. follow-up
6
32
1
58.20898
male
0
44
CHF
COPD/CHF/Cirrhosis
1
13
null
0
122,895
79,846.6875
80,763
19
white
18.296875
8
0.894897
0.823975
1
0
0
no
null
null
no dnr
44
89
7.599609
70
16
36
228.5625
4.199219
0.699951
0.799927
143
7.369141
74
10
null
0
0
no(M2 and SIP pres)
0
831
0
78.461
male
0
9
CHF
COPD/CHF/Cirrhosis
3
12
null
0
25,238
14,528.2891
13,822
22
white
24.097656
48
0.755981
0.61499
1
0
0
no
null
null
no dnr
9
83
12.599609
100
22
36.79688
null
3.699707
null
0.899902
136
null
108
34
null
1
1
no(M2 and SIP pres)
1
829
0
82.98395
male
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
3
11
under $11k
0
21,437
12,664.7109
12,816
16.5
white
32.09375
52
0.5
0.382996
4
0
0
no
null
null
dnr after sadm
6
112
11.398438
65
35
37.69531
170
null
null
0.599976
137
7.40918
71
8
1,770
0
0
no(M2 and SIP pres)
0
283
1
85.72998
male
0
5
COPD
COPD/CHF/Cirrhosis
5
13
$25-$50k
0
4,450
null
null
12
white
19.199219
39
0.755981
0.613892
1
1
0
no
0.5
0.3
dnr after sadm
2
43
16.699219
145
27
36.39844
175
2.199707
1.399902
4
139
7.369141
57
105
720
null
2
no(M2 and SIP pres)
2
372
1
78.44495
female
1
6
Coma
Coma
0
null
null
100
24,018
13,985.0547
12,876
37
black
26.796875
52
0.043999
0.021999
2
0
0
no
null
null
dnr after sadm
1
45
15
80
12
36.79688
146
2.399902
6.299805
2.899902
131
7.459961
240
83
727
null
6
<2 mo. follow-up
6
6
1
74.56799
male
0
107
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
null
174,840.875
172,957
32.75
white
33.195313
84
0.579956
0.469971
1
1
0
no
null
null
dnr after sadm
65
107
9.099609
84
30
37.69531
518.25
null
0.699951
1.199951
131
7.30957
223
14
1,170
null
null
null
2.84668
349
1
74.09198
female
0
11
Coma
Coma
0
6
under $11k
55
30,836
19,206.1094
22,714
34
white
21.5
25
0.417969
0.343994
1
0
0
no
0.5
0.5
no dnr
11
58
0.399963
135
31
37.89844
185
2
8.5
4.5
129
7.289062
63
100
440
null
4
adl>=4 (>=5 if sur)
4
824
0
43.13498
female
0
55
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
null
123,479.062
130,232
30
white
29.398438
71
0.730957
0.646973
29
1
0
no
null
null
no dnr
55
137
29.597656
145
14
36.79688
140
null
null
2.299805
150
7.449219
96
46
4,115
null
3
SIP>=30
3
824
0
52.99899
male
1
5
MOSF w/Malig
ARF/MOSF
1
12
>$50k
0
43,817
25,759.375
24,727
28
white
35.195313
55
0.250977
0.146973
8
0
0
metastatic
0.1
0
dnr after sadm
5
122
17.199219
115
22
38.89844
292.5625
null
null
1.799805
139
7.40918
251
25
3,165
null
0
<2 mo. follow-up
0
5
1
44.383
male
0
11
CHF
COPD/CHF/Cirrhosis
2
12
$25-$50k
0
24,372
14,127.7031
12,104
19.5
black
21.097656
18
0.901978
0.835938
1
0
0
no
null
null
no dnr
11
98
1
115
36
35.09375
293.3125
1.299805
11.898438
2.699707
145
7.349609
181
87
915
0
2
no(M2 and SIP pres)
2
162
1
62.771
male
0
5
Colon Cancer
Cancer
2
18
null
0
5,826
3,842.9121
3,791
7
white
43.59375
59
0.181976
0.014999
1
1
0
metastatic
0.65
0.3
no dnr
5
102
13.298828
95
28
37.29688
128.3125
null
0.799927
7.399414
137
7.439453
100
78
15
4
1
<2 mo. follow-up
1
24
1
57.30298
female
0
6
COPD
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
6,106
3,974.8887
4,224
8
white
16.097656
23
0.921997
0.86792
1
0
0
no
0.8
0.75
no dnr
6
118
18
102
40
35.09375
142.5
null
null
1.299805
135
7.399414
180
29
3,060
null
null
no(M2 and SIP pres)
2.344727
821
0
69.62396
female
1
69
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
$11-$25k
0
null
225,678.375
222,615
47
white
31.796875
57
0.557983
0.444946
10
0
0
no
0.1
0.1
dnr after sadm
67
62
11.798828
150
30
36.5
157.5
1.799805
null
0.699951
136
7.359375
95
12
950
null
5
null
5
69
1
33.94897
female
0
38
ARF/MOSF w/Sepsis
ARF/MOSF
3
9
under $11k
9
70,401
43,772.875
45,305
21.25
white
25.699219
26
0.846924
0.793945
2
0
0
no
0.5
0.5
no dnr
38
133
11.5
85
28
37.59375
null
null
0.599976
1.399902
140
null
109
18
null
null
0
null
0
820
0
80.51495
female
1
6
Coma
Coma
1
14
null
55
22,544
12,786.2422
17,636
32
white
21.199219
34
0.358948
0.28595
1
0
1
no
0.2
0.15
dnr after sadm
2
57
34.398438
95
31
37.79688
152.5
null
null
2.699707
130
7.419922
56
75
344
null
2
<2 mo. follow-up
2
6
1
64.61298
male
0
73
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
0
null
127,890.562
134,806
25.5
white
22.398438
18
0.80188
0.735962
4
0
0
no
0.8
0.75
no dnr
73
85
15.398438
55
40
35
182.5
null
null
0.899902
136
7.459961
106
20
2,680
0
0
adl>=4 (>=5 if sur)
0
819
0
61.83197
male
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
41
62,594
34,359.5938
31,317
30.5
white
19.296875
39
0.764893
0.689941
2
0
0
no
0.88
0.85
no dnr
12
32
14.599609
35
0
36.79688
140
null
null
3.5
142
7.519531
226
73
0
null
null
null
2.108887
819
0
70.70795
male
0
12
CHF
COPD/CHF/Cirrhosis
4
12
$25-$50k
0
32,075
20,653.9531
23,694
26
white
30.699219
42
0.667969
0.494995
1
1
0
no
0.6
0.5
no dnr
12
72
20.398438
105
22
37.79688
134.6875
1.899902
1.399902
1.899902
144
7.449219
137
41
2,850
null
0
no(M2 and SIP pres)
0
818
0
69.03998
male
0
3
CHF
COPD/CHF/Cirrhosis
4
11
$25-$50k
0
2,368
1,803.2598
1,889
7
white
14.798828
6
0.898926
0.830933
1
0
0
no
null
null
no dnr
3
110
16.597656
110
36
39.19531
263.3125
2.299805
3.299805
1.199951
141
7.489258
129
20
1,650
0
null
no(M2 and SIP pres)
0.494751
817
0
66.086
male
0
11
Lung Cancer
Cancer
1
3
$11-$25k
0
22,257
13,260.1797
12,577
12.5
white
18.597656
24
0.671997
0.372986
1
0
0
metastatic
1
1
no dnr
11
117
6.299805
145
8
39.5
338.0625
3
null
0.5
129
7.509766
199
12
2,750
0
0
no(M2 and SIP pres)
0
548
1
36.181
female
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
under $11k
0
25,602
16,377.4219
19,751
22
white
21
17
0.907959
0.875
1
0
0
no
0.9
0.9
no dnr
12
117
20
155
44
39.69531
117
2.399902
4.199219
0.5
144
7.329102
82
5
4,045
0
0
no(M2 and SIP pres)
0
816
0
48.99698
male
0
3
Colon Cancer
Cancer
3
9
under $11k
0
5,688
3,466.8477
2,897
1
white
15
27
0.865967
0.699951
1
0
0
metastatic
0.9
0.7
no dnr
3
65
8.199219
170
40
38.09375
136
null
null
0.699951
132
7.329102
150
7
2,570
null
null
adl>=4 (>=5 if sur)
1.943359
97
1
67.25299
male
1
9
COPD
COPD/CHF/Cirrhosis
1
17
$25-$50k
0
37,006
21,821.0156
23,331
29
white
31.898438
46
0.595947
0.405945
6
0
0
no
0.5
0.2
dnr before sadm
-5
42
0.299988
165
26
35.89844
284
null
25.097656
4.599609
141
7.369141
81
132
2,420
null
6
<2 mo. follow-up
6
9
1
51.978
female
0
6
Lung Cancer
Cancer
1
11
$11-$25k
0
12,753
6,469.1133
3,181
11
white
15.699219
13
0.760986
0.507935
1
0
0
metastatic
1
0.8
no dnr
6
123
22.898438
117
28
36.39844
164.28125
null
0.799927
0.699951
138
7.399414
211
12
1,400
0
null
no(M2 and SIP pres)
0.494751
347
1